Get the app
Kaveri Pohlman
Senior biotech analyst at Clear Street with expertise in oncology, INI (immunology and inflammation), metabolic disease, and mid‑cap biotech coverage, frequently discussing investment and development catalysts.
Best podcasts with Kaveri Pohlman
Ranked by the Snipd community
8 snips
Jan 22, 2026
• 17min
Analysts Thursdays: Clear Street Senior Biotech Analyst Kaveri Pohlman shares her take on biotech for 2026 and discusses her top picks
chevron_right
Kaveri Pohlman, Senior Biotech Analyst at Clear Street, shares insights into the biotech landscape for 2026. She highlights macro trends such as M&A and patent cliffs shaping the industry. Kaveri dives into Arrivent's pivotal readout for their EGFR TKI, Oruka's innovative psoriasis treatment, and Jade Biosciences' promising IgA nephropathy therapy. She also discusses Zura Bio's upcoming phase II data and Pavella's potential game-changing Phase III results for a rare skin disease. A fascinating look at future biotech opportunities!
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app
